Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$10.97 Mil
% of Total Estimate Gain
75.34%

SILVERARC CAPITAL MANAGEMENT, LLC's Poseida Therapeutics Inc Holding Summary

As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held - shares of Poseida Therapeutics Inc(PSTX), totaling N/A. This investment constitutes 0% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 0% of the outstanding Poseida Therapeutics Inc(PSTX) stock.

The initial trade took place in 2021Q4. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 10 purchases of PSTX, at an average price of $3.53, for a total of 4.12 Mil shares. In addition, there have been 4 sales at an average price of $6.20 for 4.12 Mil shares. Based on historical transaction data and PSTX's current price of $9.50, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his PSTX holdings is $10.97 Mil, reflecting a 75.34% gain to date.

SILVERARC CAPITAL MANAGEMENT, LLC PSTX ($9.50) Holding Chart

SILVERARC CAPITAL MANAGEMENT, LLC PSTX ($9.50) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1